Share Name Share Symbol Market Type Share ISIN Share Description
Byotrol Plc LSE:BYOT London Ordinary Share GB00B0999995 ORDS 0.25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 3.875p 3.75p 4.00p 3.875p 3.875p 3.875p 600,979 07:30:35
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Chemicals 3.1 -0.1 -0.0 - 10.39

Byotrol Share Discussion Threads

Showing 6501 to 6522 of 6525 messages
Chat Pages: 261  260  259  258  257  256  255  254  253  252  251  250  Older
DateSubjectAuthorDiscuss
10/10/2017
13:22
Good to have you on-board GW, came across another mention of Actizone in Solvays May 17 presentation. p9 hTTp://www.solvay.com/en/binaries/2017AG-jpclamadieu-presentation-en-313694.pdf
shroder
10/10/2017
10:55
Having watched this for a long time, finally decided to take an initial position given it was on offer at (just) below the placing price.
1gw
01/10/2017
20:13
There is a detailed report on Byotrol's recent AGM which can be found in our members area here: hTTps://www.sharesoc.org/members-area/ To access the report, you'll need to be a full member of ShareSoc, which is a not-for-profit organisation that supports individual shareholders and campaigns for shareholder rights. If you're not already a member you can join here: hTTps://www.sharesoc.org/membership/ Once you've joined, you'll receive an invitation to register for our "members network" private social network, from where you'll be able to access the report (and reports on 100s of other meetings). If you're already a member and have any difficulty accessing the report, please do not hesitate to contact us here: hTTps://www.sharesoc.org/contact-us/
sharesoc
01/10/2017
17:05
Thanks for the AGM feedback, few snippets on LSE from another attendee. I thought Solvay may do another Capital Market day this Sept but nothing as yet. Last years presentation mentioned Actizone (p18) as part of their technology portfolio section. hTTp://www.solvay.com/en/binaries/2016CMD-Advanced-formulations-294708.pdf hTTp://actizone.com/
shroder
30/9/2017
21:43
Okay, now that it has been on the ShareSoc members' network for a few days, here is the text of my AGM Report that I posted there (with a few typos corrected). With hindsight I should have paid more attention to the part of the presentation concerning the product range, but as it was my first Byotrol meeting I was more interested in getting a broad-brush overview of the company and its management rather than specific product detail. __________________________________________ Byotrol plc AGM 2017 On Friday 28th September 2017 I attended the AGM of Byotrol plc at the London offices of finnCap, a venue that will be familiar to some ShareSoc members as it previously hosted many of its London Company Seminars. The company describes itself as ‘an expert developer of consumer and professional antimicrobial technologies and products’ and more details can be found on its website www.byotrol.co.uk . All four Directors were present, as was Company Secretary Denise Keenan, who welcomed us into to the meeting room, where tea, coffee, biscuits and copies of the Annual Report and Notice of AGM were available. There were 17 people in the room in total and I would estimate that about seven or eight of us were private investors. After a brief introduction by Chairman John Langlands, Chief Executive David Traynor gave his presentation. He has been at the helm since 2013 and said that he and others ‘bear the scars of the last four years’, when the company would appear to have led something of a hand-to-mouth existence on a shoestring. However, a successful fundraising earlier this year raised around £4 million, which Traynor said gives them the financial resources necessary to face the next phase of the company’s development with ‘confidence and firepower’. In 2013 the company had 32 staff in total, of whom seven were tech staff. That total number has now reduced to 17 but the tech headcount remains unchanged on seven, which indicates what Byotrol’s priorities were over that period. That has inevitably left them short in other areas and some of the new funds will be used to establish a new sales, marketing and PR team – this is a big priority for Traynor. As he put it: ‘The technology has been developed, now we need to deliver it’. The company considers itself to be a ‘chemical technology company’ and the presentation identified three growth areas: • Surface care (US) • Surface care (Europe and the Rest of the World) • Hand sanitisation The presentation then gave details of some of Byotrol’s current products. The website (hTTp://www.byotrol.co.uk/products/) describes them with more clarity than I could attempt in this brief report. Traynor stressed that Byotrol’s ‘excellent science’ would enable it to achieve high margins in those areas. A brief Q&A session was cordial and didn’t unveil anything new of significance – unless I missed anything of course. Then it was down to the formal business and all six resolutions were passed without dissent on a show of hands and by very comfortable margins on proxy votes. Afterwards there was the opportunity to chat with the Directors and others present over coffee. I had a brief chat with David Traynor and a slightly longer one with Non-Executive Till Medinger. Perhaps my overarching impression from the meeting is that, buoyed by the successful fundraising, the Directors are looking forward to an exciting time ahead for the company. To their credit, both Traynor in his presentation and Medinger when I spoke with him afterwards, didn’t resort to ramptastic hyperbole. It was a case of: We know what we need to do, we have the funds to enable us to do it, now it’s up to us to make sure we deliver. I am a new shareholder in Byotrol, having taken a small stake in the placing, and this was my first opportunity to attend one of their presentations and meet the management. Having done so, I am very happy to hold that small stake and follow developments over the next year with interest. ______________________________________ Ends
gostevie63
30/9/2017
06:14
Stevie. Can we read your report please
wisecat2
29/9/2017
22:52
Cheers Stevie, is associate membership sufficient or do you need the full Monty for access? Couple of bits of general interest: ______________________________________________________ Introducing the New American Red Cross Hand Sanitizer hTTp://www.myhandsanitizer.com/ ______________________________________________________ Solvay appear to have a dedicated chap promoting Actizone Regional Marketing Director for Novecare / Global Marketing Actizone & Emollients Solvay April 2017 – Present (6 months)São Paulo Area, Brazil hTTps://www.linkedin.com/in/neil-barrientos-080a7894
shroder
28/9/2017
22:59
Thanks Steve, I will review my hand-written notes from the Sept 4th General meeting over the weekend to see if there is anything else that I could add which may be of interest.
timbo003
28/9/2017
18:47
AGM report now posted. The link is here. hTTp://sharesoc.ning.com/xn/detail/6389471:Comment:46224 With apologies for any errors or significant omissions.
gostevie63
28/9/2017
12:07
I attended the AGM this morning. All very cordial and uncontroversial. 17 people in the room, of whom I'd guess about 7 or 8 of us were private investors. A clear and honest presentation from David Traynor, who emphasised that the challenge and priority now is to deliver sales. To this end he will be using some of the placing funds to build a sales and marketing team. All resolutions passed without dissent on a show of hands, and comfortably on proxy votes. Seems like an exciting time for the Company. I'll endeavour to do a write-up for ShareSoc over the weekend.
gostevie63
06/9/2017
14:54
Register building nicely, Fidelity and Maven Cap now added, not sure about the form used 8.3?
shroder
06/9/2017
09:39
Not sure either, nice back stop though - very impressed with the Red Cross product stateside, new 'pen type' applicator too.
shroder
06/9/2017
09:33
Shroder Almost certainly yes. I was at the meeting on Monday (brief notes to follow) and I asked the question. I think they said there should be 3 notifications, I don't know whether Amati counts as one or two. Edit: I read the slightly confusing RNS announcements that the Amarti funds have 6.2% (not 12%) in total, although I may be wrong on that.
timbo003
06/9/2017
09:29
Looks like just over 12% for Amati various funds, few more to declare?
shroder
01/9/2017
08:49
Forgotten your eloquence tablets again Chimers?
milesy
01/9/2017
08:01
I cannot make it to the AGM this year (on September 28th), so will go along to the General meeting on this next Monday (September 4th) instead to ask a few questions. Anyone else intending to go to either meeting?
timbo003
31/8/2017
21:21
Glad your not a cynic then maxk, can't say as I blame you though, has taken an age. That said, firmly behind David and the team as Byotrol would have been in a right pickle without him.
shroder
31/8/2017
08:38
Well, that's the beer money secured.
maxk
17/8/2017
15:32
It look like institutional buying, perhaps those participating in the fund raise didn't get their full allocation?
shroder
17/8/2017
15:05
....well the approval from the States is a huge step in itself ?
emeraldzebra
15/8/2017
23:32
And that is the issue really; is this management team really up to the job of commercialisation? That's my huge stumbling block here - otherwise it's just raise, burn and repeat.
dan_the_epic
15/8/2017
22:50
The recent fund raiser keeps the wages being paid, what more do you want?
maxk
Chat Pages: 261  260  259  258  257  256  255  254  253  252  251  250  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:33 V: D:20171019 12:48:32